Hims Hers $1.2 Billion Global Leap Draws Investor Scrutiny
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Common errors include vague categories and infrequent reviews. Regular checks keep Zero Based Budgeting precise and helpful.
18,324 articlesHims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
The AI era has reshaped Palantir's role in enterprise data. This guide weighs the buy, sell, hold case for 2026 with ...
Thirty-five donor families pledged $1.03 billion to multi-year initiatives across the U.S. and beyond, a landmark dis...
Lilly shares moved lower after Novo Nordisk announced price cuts on leading obesity drugs, signaling a tougher compet...
Bilt rolls out an AI-driven Neighborhood Concierge to challenge Amazon in the home-commerce space, promising seamless...
Brace yourself for a clear, investor-friendly read on chord energy (chrd) 2025 Q4 results. This deep dive breaks down...
MercadoLibre faced a sharp price move after a quarter that showed strong top-line momentum but weaker profitability. ...
U.S. manufacturers grow second month in a row in February, but tariff-driven pricing pressures and volatile metal cos...
February delivered a sharp setback for AMZN as investors weighed another wave of capital spending against growth pros...
February delivered a sharp pullback for HECM endorsements, with lenders trimming activity and regions posting broad-b...
A hedge fund quietly doubled down with an $8 million bet as euronet stock tanked this past year. Here’s what that mov...
A recent price retreat for AMD has more to do with market nerves than a broken thesis. This article lays out why inve...